832-497-2220 info@mybiogate.com

Ambrx partners with BeiGene to Develop Next-Generation Biologics

March, 2019, Ambrx, Inc. and BeiGene, Ltd announced a global research and development collaboration.  BeiGene is a global, commercial-stage, research-based biotechnology company focused on immuno-oncology cancer therapeutics. With a team of over 2,200 employees in...

Biomedical Conferences Help You Stay Apprised of Industry Trends

How do you feel about bio-medical conferences, conventions, and health summits? Do you love attending? Do you navigate the floor with ease or are you not sure where to go, or perhaps see it as a significant expense? Once you sort through the number of conferences...

China implements key regulatory changes to accelerate drug approval

China pharma sector, the second largest in the world, continues to grow rapidly on a CAGR of 10%, which will reach ~$393 Billion in 2025.  Key regulatory changes •   China Joined ICH in 2017: fast drug approval and match the global standards •   NRDL (National...
|JPM Week | Guidebook

|JPM Week | Guidebook

Introduction J.P. Morgan 38th Annual Healthcare Conference (JPM 2020) will take place 13-16 January 2020 in San Francisco, CA, USA. The annual J.P. Morgan Healthcare Conference is the largest and most informative healthcare investment symposium in the industry,...
Case Studies: Things you need to know about China partnering

Case Studies: Things you need to know about China partnering

In 2018, Chinese companies made more than 150 cross-border life sciences licensing deals, with the average upfront payment of ~$10 Million, having reached a record high. Over 40% of early- and late-stage assets entered China market through licensing deals.  In this...

Top China VCs who matters in healthcare, but you hardly know

Forbes released its annual Midas List of the best dealmakers in venture capital and the Chinese were outstanding in the 2019 rankings. Selected Deals in 2019 Apic Bio completed a $40 million Series A financing led by Morningside Venture Cullgen of San Diego Raises $16...

Will You Interested In Partnering With These Chinese Organizations

MyBioGate Global Healthcare Innovation Competition is a cross-border platform that connects global innovations in healthcare with the growing market, capital, and resources in China. We aim to help companies from overseas find out and connect with trustworthy Chinese...

Connect Your Medical Imaging Projects With Chinese Investors

Join us at the new module of China Focus@ San Francisco: Medical Device Challenge, a medical device focused partnering and presenting meeting.Apply now and win the complimentary general admission. What is Medical Device Challenge?         What can I get?       ...